8 results match your criteria: "Beijing Zhendong Guangming Pharmaceutical Research Institute Co.[Affiliation]"
J Control Release
January 2025
State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, and School of Pharmaceutical Sciences, Peking University, Beijing, China. Electronic address:
Drug delivery efficiency often affects chemotherapy outcome due to dense collagen barrier in tumor environment. Here, we report a nanoparticle capable of pH and glutathione dual-responsive drug delivery to enhance the efficacy of breast cancer chemotherapy. Maleiminated polyethylene glycol and polylactide block copolymer were synthesized as a core material, doxorubicin was encapsulated into the nanoparticle by self-assembly.
View Article and Find Full Text PDFJ Ethnopharmacol
October 2023
Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100102, China. Electronic address:
Ethnopharmacological Relevance: Compound Kushen injection (CKI) is a representative medication of Chinese herbal injection and is often used in the adjuvant treatment of nasopharyngeal carcinoma (NPC), but its antitumor mechanism is poorly understood.
Aim Of The Study: To preliminarily elucidate the effects and possible mechanisms of CKI on NPC.
Methods: In this work, we explored the possible molecular mechanisms of CKI against NPC by using network pharmacology and molecular docking.
Zhongguo Zhong Yao Za Zhi
August 2022
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
Zhongguo Zhong Yao Za Zhi
May 2022
Beijing Zhendong Guangming Pharmaceutical Research Institute Co., Ltd. Beijing 100085, China.
This study aims to evaluate the anti-tumor and analgesic activities of Compound Kushen Injection(CKI) based on zebrafish model in vivo and investigate the anti-tumor mechanism. To be specific, zebrafish tumor xenotransplantation model was established by microinjection of murine LPC H12 cells into yolk sac. Then the high-dose CKI(H-CKI), medium-dose CKI(M-CKI), low-dose CKI(L-CKI) groups, and the model group were set.
View Article and Find Full Text PDFMedicine (Baltimore)
July 2021
Department of Science and Education, Heping Hospital Affiliated to Changzhi Medical College, Shanxi, Changzhi City, PR China.
Thirty-five previous meta-analyses have been reported on the individual glutathione S-transferase M1 (GSTM1) present/null, glutathione S-transferase T1 (GSTT1) present/null, and glutathione S-transferase P1 (GSTP1) IIe105Val polymorphisms with lung cancer (LC) risk. However, they did not appraise the credibility and explore the combined effects between the 3 genes and LC risk.We performed a meta-analysis and re-analysis of systematic previous meta-analyses to solve the above problems.
View Article and Find Full Text PDFZhongguo Zhong Yao Za Zhi
October 2020
Modern Research Center for Traditional Chinese Medicine, Shanxi University Taiyuan 030006, China.
Qizhi Tongluo Capsules, which is composed of 26 herbal drugs, is mainly used as the assistant therapy for apoplexy sequelae. The chemical composition of Qizhi Tongluo Capsules was complex,but its chemical constituents and the pharmacodynamic material basis remain unreported. The ultrahigh performance liquid chromatography coupled with hybrid quadrupole-orbitrap mass spectrometry(UPLC-Q-Orbitrap HRMS) was applied to recognize the chemical constituents of Qizhi Tongluo Capsules.
View Article and Find Full Text PDFMedicine (Baltimore)
November 2019
Department of Neurology, Heping Hospital Affiliated to Changzhi Medical College, Shanxi Province.
Rationale: Due to the rarity of bilateral cerebral peduncular infarction (BCPI), its symptoms and prognosis are not clear. It is necessary to collect cases of pure cerebral peduncular infarction, explore the etiology and anatomy of midbrain infarction in depth, and develop meaningful tools for explaining clinical symptoms and predicting prognosis of patients.
Patient Concerns: We here provide a case of isolated BCPI with uncommon symptoms of ataxia, dysarthria, sensory disturbance, normal muscular strength, and full eye movements.
Acta Pharmacol Sin
June 2015
Shanxi Zhendong Pharmaceutical Co Ltd, Changzhi 047100, China.
Kushen (Radix Sophorae Flavescentis) has a long history of use for the treatment of tumors, inflammation and other diseases in traditional Chinese medicine. Compound Kushen Injection (CKI) is a mixture of natural compounds extracted from Kushen and Baituling (Rhizoma Smilacis Glabrae). The main principles of CKI are matrine (MT) and oxymatrine (OMT) that exhibit a variety of pharmacological activities, including anti-inflammatory, anti-allergic, anti-viral, anti-fibrotic and cardiovascular protective effects.
View Article and Find Full Text PDF